Pharmaceutical

Cipla and Glenmark initiate recall of certain products in the US

Cipla and Glenmark Pharmaceuticals are recalling specific products from the US market due to distinct manufacturing issues.

May 7, 2024 - 00:00
Cipla and Glenmark initiate recall of certain products in the US
Cipla and Glenmark Pharmaceuticals are recalling specific products from the US market due to distinct manufacturing issues.
Read the original article

Tags:

Previous Article

Fighting cancer with artificial cells

Next Article

Lantern Pharma and Oregon partner to develop cancer treatment

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

How competitive intelligence can give pharma companies an edge

How competitive intelligence can give pharma companies ...

Aug 18, 2023

Superbugs, antibiotic resistance get renewed scrutiny in Congress

Superbugs, antibiotic resistance get renewed scrutiny i...

Jul 12, 2023

Tevogen to go public in $1.2bn SPAC deal

Tevogen to go public in $1.2bn SPAC deal

Jun 29, 2023